Latigo Biotherapeutics logo
Latigo Biotherapeutics, Inc. (LTGO)
NASDAQ: LTGO · Real-Time Price · USD
14.76
+0.76 (5.43%)
Oct 15, 2026, 4:00 PM EDT - Market closed

Latigo Biotherapeutics Statistics

Total Valuation

LTGO has a market cap or net worth of $978.58 million. The enterprise value is $954.83 million.

Market Cap978.58M
Enterprise Value 954.83M

Important Dates

The next estimated earnings date is Thursday, November 19, 2026, before market open.

Earnings Date Nov 19, 2026
Ex-Dividend Date n/a

Share Statistics

LTGO has 66.30 million shares outstanding.

Current Share Class 66.30M
Shares Outstanding 66.30M
Shares Change (YoY) n/a
Shares Change (QoQ) +2.88%
Owned by Insiders (%) 6.52%
Owned by Institutions (%) 6.44%
Float 21.74M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 78.27
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 2.50.

Current Ratio 1.15
Quick Ratio 1.07
Debt / Equity 2.50
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -447.73

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -852.32%
Weighted Average Cost of Capital (WACC) n/a
Revenue Per Employee n/a
Profits Per Employee -$1.68M
Employee Count 66
Asset Turnover n/a
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) 36.13
Average Volume (20 Days) 416,477

Short Selling Information

The latest short interest is 832,088, so 1.26% of the outstanding shares have been sold short.

Short Interest 832,088
Short Previous Month 449,962
Short % of Shares Out 1.26%
Short % of Float 3.83%
Short Ratio (days to cover) 2.26

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -112.38M
Pretax Income -111.14M
Net Income -111.14M
EBITDA -112.16M
EBIT -112.38M
Earnings Per Share (EPS) -$116.74
Full Income Statement

Balance Sheet

The company has $55.00 million in cash and $31.25 million in debt, with a net cash position of $23.75 million or $0.36 per share.

Cash & Cash Equivalents 55.00M
Total Debt 31.25M
Net Cash 23.75M
Net Cash Per Share $0.36
Equity (Book Value) 12.50M
Book Value Per Share -279.37
Working Capital 7.62M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$103.19 million and capital expenditures -$111,000, giving a free cash flow of -$103.30 million.

Operating Cash Flow -103.19M
Capital Expenditures -111,000
Depreciation & Amortization 215,000
Net Borrowing 35.00M
Free Cash Flow -103.30M
FCF Per Share -$1.56
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

LTGO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -11.36%
FCF Yield -10.56%

Analyst Forecast

The average price target for LTGO is $52.25, which is 254.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target $52.25
Price Target Difference 254.00%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 1